Crowdonomics
Advanced Bio-Oil Technologies Ltd.

Reg A+ · Equity · Sep 2017

ClosedReg A+Equity
via the platform · last checked Sep 24, 2026
Raised
$0 / $25M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

8 amendments
  1. Nov 12, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Oct 15, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  3. Sep 2, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  4. Jun 8, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  5. Aug 16, 2018
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  6. Aug 7, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  7. Aug 2, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  8. Jul 27, 2017
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Price / share$0.50
Shares offered50,000,000

Offering details

Target—
Max$25,000,000
Min investment—
OpenedSep 18, 2017
Deadline—
ClosedSep 18, 2020
Days active1,096

Links & provenance

Source: SEC EDGAR
0001683168-17-001312
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.